The state agency that oversees juvenile prisons is changing the way it distributes powerful antipsychotic medications in response to a series published two years ago in The Palm Beach Post.
But the Department of Juvenile Justice rejected the series’ thrust, saying drugs have not become “chemical restraints,” controlling youth in state-run jails and residential centers.
Subscribers get total access to this story, and all our in-depth news, digital editions and exclusive content. Subscribe today, or try a 24-hour or 7-day digital pass.
Registered Post Subscriber — Sign me in.Sign In
Post Print Subscriber — I need to register my account for digital access.Access Digital
All Day Access — 24-hour digital pass99¢ for 24 hours
All Week Access — 7-day digital pass$3.99 for 7 days
All Access, All the Time — Print & DigitalView Offers
What The Post Found
The Department of Juvenile Justice bought 326,081 tablets of antipsychotic drugs, including Seroquel, Abilify and Risperdal over a two-year period. That’s enough to hand out 446 pills a day, seven days a week, for two years in a row, to kids in jails and programs holding 2,300 children. One in three psychiatrists who contracted with DJJ over a five-year period took speaker fees and gifts from the pharmaceutical industry.